Study #2024-0388
Neoadjuvant immune checkpoint blockade + a prebiotic food-enriched dietary intervention to optimize immune response in melanoma: NEO-PreFED
MD Anderson Study Status
Enrolling
Treatment Agent
Dietary Supplement: Prebiotic Xnack Packouts
Description
To Determine the feasibility, compliance and adherence to PreFED intervention in resectable melanoma patients initiating neoadjuvant Ipi/Nivo.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Melanoma
Study phase:
Phase II
Physician name:
Jennifer McQuade
Department:
Melanoma Medical Oncology
For general questions about clinical trials:
1-844-296-9573
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.